These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 32420695)
1. A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia. Tak YJ; Lee SY; Cho AR; Kim YS Stem Cells Transl Med; 2020 Aug; 9(8):839-849. PubMed ID: 32420695 [TBL] [Abstract][Full Text] [Related]
2. The Effect of Conditioned Media From Human Adipocyte-Derived Mesenchymal Stem Cells on Androgenetic Alopecia After Nonablative Fractional Laser Treatment. Lee YI; Kim J; Kim J; Park S; Lee JH Dermatol Surg; 2020 Dec; 46(12):1698-1704. PubMed ID: 32769526 [TBL] [Abstract][Full Text] [Related]
3. Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial. Legiawati L; Suseno LS; Sitohang IBS; Yusharyahya SN; Pawitan JA; Liem IK; Kurniawati T; Ardelia A; Paramastri K Stem Cell Res Ther; 2023 Aug; 14(1):210. PubMed ID: 37605227 [TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study. Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-Comparison, Sham Device-Controlled Trial. Mai-Yi Fan S; Cheng YP; Lee MY; Lin SJ; Chiu HY Dermatol Surg; 2018 Nov; 44(11):1411-1420. PubMed ID: 29957664 [TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503 [TBL] [Abstract][Full Text] [Related]
8. Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. Suchonwanit P; Chalermroj N; Khunkhet S Lasers Med Sci; 2019 Aug; 34(6):1107-1114. PubMed ID: 30569416 [TBL] [Abstract][Full Text] [Related]
9. Sequential Scalp Assessment in Hair Regeneration Therapy Using an Adipose-Derived Stem Cell-Conditioned Medium. Narita K; Fukuoka H; Sekiyama T; Suga H; Harii K Dermatol Surg; 2020 Jun; 46(6):819-825. PubMed ID: 31490301 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double-blind, randomized controlled trial study. Masoud F; Alamdari HA; Asnaashari S; Shokri J; Javadzadeh Y Dermatol Ther; 2020 Nov; 33(6):e14467. PubMed ID: 33112463 [TBL] [Abstract][Full Text] [Related]
11. Topical valproic acid increases the hair count in male patients with androgenetic alopecia: a randomized, comparative, clinical feasibility study using phototrichogram analysis. Jo SJ; Shin H; Park YW; Paik SH; Park WS; Jeong YS; Shin HJ; Kwon O J Dermatol; 2014 Apr; 41(4):285-91. PubMed ID: 24533507 [TBL] [Abstract][Full Text] [Related]
12. Growth factor concentrations in platelet-rich plasma for androgenetic alopecia: An intra-subject, randomized, blinded, placebo-controlled, pilot study. Siah TW; Guo H; Chu T; Santos L; Nakamura H; Leung G; Shapiro J; McElwee KJ Exp Dermatol; 2020 Mar; 29(3):334-340. PubMed ID: 31984508 [TBL] [Abstract][Full Text] [Related]
13. Reduction of telogen rate and increase of hair density in androgenetic alopecia by a cosmetic product: Results of a randomized, prospective, vehicle-controlled double-blind study in men. Welzel J; Wolff HH; Gehring W J Cosmet Dermatol; 2022 Mar; 21(3):1057-1064. PubMed ID: 33955628 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730 [TBL] [Abstract][Full Text] [Related]
15. Adipose-derived stem cell conditioned medium for hair regeneration therapy in alopecia: a review of literature. Legiawati L; Suseno LS; Sitohang IBS; Yusharyahya SN; Fahira A; Ramadan ET; Paramastri K Arch Dermatol Res; 2024 Aug; 316(8):525. PubMed ID: 39153118 [TBL] [Abstract][Full Text] [Related]
16. Contrast enhanced phototrichogram pinpoints scalp hair changes in androgen sensitive areas of male androgenetic alopecia. Leroy T; Van Neste D Skin Res Technol; 2002 May; 8(2):106-11. PubMed ID: 12060475 [TBL] [Abstract][Full Text] [Related]
17. HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial. Leavitt M; Charles G; Heyman E; Michaels D Clin Drug Investig; 2009; 29(5):283-92. PubMed ID: 19366270 [TBL] [Abstract][Full Text] [Related]
18. Heat-treated Limosilactobacillus fermentum LM1020 with menthol, salicylic acid, and panthenol promotes hair growth and regulates hair scalp microbiome balance in androgenetic alopecia: A double-blind, randomized and placebo-controlled clinical trial. Bae WY; Jung WH; Shin SL; Kim TR; Sohn M; Suk J; Jung I; Lee YI; Lee JH J Cosmet Dermatol; 2024 Sep; 23(9):2943-2955. PubMed ID: 38807549 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of platelet-rich plasma as a treatment for androgenetic alopecia: A randomized controlled trial. Shapiro J; Ho A; Sukhdeo K; Yin L; Lo Sicco K J Am Acad Dermatol; 2020 Nov; 83(5):1298-1303. PubMed ID: 32653577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]